GHK-Cus ability to remodel scar tissue through its balanced MMP regulation (breaking down disorganized collagen in scars while promoting new, organized collagen formation) makes it particularly relevant for improving the appearance of stretch marks alongside loose skin
Screening may be warranted in patients with one or more risk factors, such as gastric or small intestine resections, inflammatory bowel disease, use of metformin for more than four months, use of proton pump inhibitors or histamine H 2 blockers for more than 12 months, vegans or strict vegetarians, and adults older than 75 years
BPC-157 is used as an adjunct, not a replacement, for standard post-op care
The longest animal studies on BPC-157 span approximately 4 weeks to 12 weeks, leaving the safety profile for use extending beyond 3 months entirely undocumented in peer-reviewed literature